Results

Total Results: 1,091 records

Showing results for "cardiovascular".
Users also searched for: statin

461. Vascular Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/vascular-diseases?page=3
     February 17, 2011 - Stents in the Elderly: Results From 262,700 Patients in the American College of Cardiology-National Cardiovascular

462. Methods-Balancing-Harms-Benefits Research-2012 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
     January 01, 2012 - hazards of rofecoxib and also provided evidence that naproxen offered no such cardiovascular benefit … , 18 and may also carry a smaller cardiovascular hazard. … risk does not validate the use of thiazolidinediones to lower cardiovascular risk. … Aspirin for the prevention of cardiovascular disease: U.S. … Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

463. Selecting Observational Studies for Comparing Medical Interventions | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guidance-observational-studies/methods
     April 01, 2022 - The review also included 96 articles reporting findings from 10 large cardiovascular registries. … subjects participating in the Heart Protection Study. 20 No beneficial effects were seen in numerous cardiovascular … applicability of the findings of the Heart Protection Study to most adults with an elevated risk of cardiovascular … Protocol Nov 15, 2024 Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular … Research Protocol Nov 15, 2024 Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular

464. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
     April 01, 2020 - NSAIDs have increased risk of serious gastrointestinal, liver dysfunction, and cardiovascular adverse … The risk of any cardiovascular event was not significantly elevated for NSAIDs as a group, but diclofenac … There was no difference in cardiovascular events between celecoxib and 7 nonselective NSAIDs in … In the short term, the risk of any cardiovascular event was not significantly elevated for NSAIDs as … In the intermediate and long term, there was not a difference in cardiovascular events between drugs

465. Recombinant-Factor-Viia Clinician (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
     October 01, 2010 - 2000Year 2001 2002 2003 2004 2005 2006 2007 2008 Hemophilia Spontaneous intracranial hemorrhage Trauma Cardiovascular

466. Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/
     April 11, 2025 - Persons Systematic Review   March 3, 2025 Association of Digestible Carbohydrate Intake With Cardiovascular

467. Interventions for Preventing Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Disease | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cognitive-decline/research-protocol
     December 01, 2020 - associated with an increased risk of developing MCI and Alzheimer's disease, including depression, cancer, cardiovascular … Examples include treatment and control of chronic medical or mental health conditions (i.e., cardiovascular … Interventions Examples Aspirin/nonsteroidal anti-inflammatory drugs NSAIDS Cardiovascular … We will examine the treatment of diseases such as cardiovascular disease, cerebrovascular disease, hypertension

468. Change Score or Followup Score? An Empirical Evaluation of the Impact of Choice of Mean Difference Estimates | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/choice-of-mean/white-paper
     November 01, 2017 - Protocol Nov 15, 2024 Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular

469. Use of Handheld Devices for Point of Care Decision Support (Session II) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/eccs-2009/white-paper-2009-2
     July 01, 2019 - Research Protocol Dec 21, 2023 The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular

470. Future Research Needs for Childhood Obesity Prevention Programs | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/child-obesity-future/research
     December 01, 2019 - Childhood obesity leads to obesity in adulthood and many other serious health conditions, such as cardiovascular

471. Impact of Community Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/health-worker-certification/technical-brief
     July 01, 2020 - find any studies evaluating the effect of community health worker certification on asthma, diabetes, cardiovascular

472. Data Points #14: Use of endocrine therapy following diagnosis of ductal carcinoma in situ or early invasive breast cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/dcis-endocrine-therapy/research
     December 01, 2019 - AI use is associated with increased cardiovascular disease, bone loss, and painful joints.

473. Symposium on Methods for Developing and Analyzing Clinically Rich Data for Patient-Centered Outcomes Research - Part III | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/patient-outcomes-symposium/overview
     November 01, 2018 - Research Protocol Dec 21, 2023 The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular

474. Childhood Obesity Prevention Programs: Comparative Effectiveness Review and Meta-Analysis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/obesity-child/research
     December 01, 2019 - Protocol Nov 15, 2024 Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular

475. Safety of Vaccines Used for Routine Immunization in the United States | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/vaccine-safety/research
     April 01, 2020 - Guillain-Barré syndrome (GBS); and a lack of association between influenza and pneumococcal vaccines and cardiovascular

476. Horizon Scanning Protocol and Operations Manual January 2013 Revision (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
     August 01, 2013 - Cardiovascular disease 4. Dementia (including Alzheimer’s Disease) 5. … journal from the American Heart Association that publishes original medical research related to cardiovascular … Therapeutics) is the world's largest educational meeting specializing in interventional cardiovascular … information focusing on the development, sales, and marketing of major therapeutic categories - Cardiovascular … exploratory search of a priority area Set number Concept Search Statement 1 Stroke (part of cardiovascular

477. Breastfeeding and Health Outcomes for Infants and Children | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/breastfeeding-health-outcomes/research
     March 01, 2025 - and allergic conditions, oral health, autoimmune gastrointestinal conditions, endocrine conditions, cardiovascular

478. What is the comparative renal of differnt contrast media used in radiographic imaging ? What is the comparative efficacy of different therapies in preventing contrast induced nephropathy? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-renal-of-differnt-contrast-media-used-in-radiographic-imaging-what-is-the-comparative-efficacy-of-different-therapies-in-preventing-contrast-induced-nephropathy
     November 01, 2017 - (check all that apply) EHC Priority Conditions (updated in 2008) Cardiovascular disease, including

479. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_executive.pdf
     September 01, 2009 - postmenopausal women meeting breast cancer risk criteria and to older postmenopausal women with osteoporosis or cardiovascular … disease and/or risk factors for cardiovascular disease.

480. Topic Nomination: Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia 1.Questions to Consider 1. What is the comparative efficacy and effectiveness of currently available and emerging treatments for lower urinary tract… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/topic-nomination-lower-urinary-tract-symptoms-secondary-to-benign-prostatic-hyperplasia-1questions-to-consider-1-what-is-the-comparative-efficacy-and-effectiveness-of-currently-available-and-emerging-treatments-for-lower-uri
     November 01, 2017 - In particular what is the incidence of adverse cardiovascular effects during treatment of LUTS/BPH utilizing … /IPSS, peak flow rate, QoL question score, BPH impact index), retention, asthenia, breast symptoms, cardiovascular